{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:07:49Z","timestamp":1790521669196,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["812890 - ArthritisHeal"],"award-info":[{"award-number":["812890 - ArthritisHeal"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite introduction of biological disease modifying anti-rheumatic drugs (DMARDs) for Rheumatoid arthritis (RA) treatment, therapeutic strategies do not always lead to disease control and remission. Hence, a more efficient patient stratification and monitoring biomarkers and tools are needed to enable a more personalized medicine. We used a whole blood based functional flow cytometry assay to characterize immune cells from RA patients (treated or not), healthy donors and psoriatic arthritis (PsA) patients according to their responses to LPS and\/or anti-TNF\u03b1 (infliximab, IFX). Activation marker expression was measured using a 10-color flow cytometry panel following a no-wash protocol. Na\u00efve-to-treatment RA patients had a stronger inflammatory profile in comparison to healthy donors at basal level. Higher expression of activation markers (CD69 and\/or CD11b) on NK, B cells and granulocytes and lower expression of the adhesion molecule CD62L were measured on monocytes, granulocytes and B cells. After LPS, na\u00efve RA patients\u2019 cells were less capable of regulating CD69, CD11b, CD16 or CD62L showing impaired activation capabilities. Upon LPS and IFX co-incubation, hierarchical clustering analysis showed different profiles between cohorts. We believe that this whole blood-based approach should further be assessed for RA patient characterization as it provides new perspectives for stratification and\/or monitoring.<\/jats:p>","DOI":"10.1038\/s41598-022-16622-4","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T10:16:02Z","timestamp":1657966562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research"],"prefix":"10.1038","volume":"12","author":[{"given":"Celia","family":"Cartagena Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Balandraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Roudier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lafforgue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Busnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,16]]},"reference":[{"key":"16622_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens, G. A. et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43, 155\u2013163 (2000).","journal-title":"Arthritis Rheum."},{"key":"16622_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03009740310003677","volume":"32","author":"K Suzuki","year":"2003","unstructured":"Suzuki, K. et al. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand. J. Rheumatol. 32, 197\u2013204 (2003).","journal-title":"Scand. J. Rheumatol."},{"key":"16622_CR3","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1038\/s41598-021-84963-7","volume":"11","author":"S Mishima","year":"2021","unstructured":"Mishima, S. et al. Higher PGD(2) production by synovial mast cells from rheumatoid arthritis patients compared with osteoarthritis patients via miR-199a-3p\/prostaglandin synthetase 2 axis. Sci. Rep. 11, 5738 (2021).","journal-title":"Sci. Rep."},{"key":"16622_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429\u2013442 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"16622_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","volume":"117","author":"D Tracey","year":"2008","unstructured":"Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G. & Tak, P. P. Tumor necrosis factor antagonist mechanisms of action: A comprehensive review. Pharmacol. Ther. 117, 244\u2013279 (2008).","journal-title":"Pharmacol. Ther."},{"key":"16622_CR6","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester, G. R. & Pope, J. E. Novel treatment strategies in rheumatoid arthritis. Lancet 389, 2338\u20132348 (2017).","journal-title":"Lancet"},{"key":"16622_CR7","first-page":"16","volume":"124","author":"ME Weinblatt","year":"2013","unstructured":"Weinblatt, M. E. Methotrexate in rheumatoid arthritis: A quarter century of development. Trans. Am. Clin. Climatol. Assoc. 124, 16 (2013).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"16622_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/14712598.2020.1802421","volume":"21","author":"M Dey","year":"2021","unstructured":"Dey, M., Zhao, S. S. & Moots, R. J. Anti-TNF biosimilars in rheumatology: The end of an era?. Expert Opin. Biol. Ther. 21, 29\u201336 (2021).","journal-title":"Expert Opin. Biol. Ther."},{"key":"16622_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann. Rheum. Dis. 79, 685\u2013699 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"16622_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.4049\/immunohorizons.2000077","volume":"4","author":"CC Garc\u00eda","year":"2020","unstructured":"Garc\u00eda, C. C., Lef\u00e8vre, A. & Busnel, J.-M.R. Development of a flow cytometry-based functional assay to study anti-TNF mechanisms of action and capture donor heterogeneity. ImmunoHorizons 4, 648\u2013658 (2020).","journal-title":"ImmunoHorizons"},{"key":"16622_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1172\/JCI115338","volume":"88","author":"A Laffon","year":"1991","unstructured":"Laffon, A. et al. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J. Clin. Invest. 88, 546\u2013552 (1991).","journal-title":"J. Clin. Invest."},{"key":"16622_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/intimm\/dxg102","volume":"15","author":"K Murata","year":"2003","unstructured":"Murata, K. et al. CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int. Immunol. 15, 987\u2013992 (2003).","journal-title":"Int. Immunol."},{"key":"16622_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/ar1803","volume":"7","author":"F Capsoni","year":"2005","unstructured":"Capsoni, F. et al. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res. Ther. 7, 208 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"16622_CR14","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.3389\/fimmu.2019.02384","volume":"0","author":"A Leite Pereira","year":"2019","unstructured":"Leite Pereira, A. et al. Characterization of phenotypes and functional activities of leukocytes from rheumatoid arthritis patients by mass cytometry. Front. Immunol. 0, 2384 (2019).","journal-title":"Front. Immunol."},{"issue":"10","key":"16622_CR15","first-page":"1","volume":"2020","author":"S-J Lin","year":"2020","unstructured":"Lin, S.-J. et al. Phenotypic and functional characterization of natural killer cells in rheumatoid arthritis-regulation with interleukin-15. Sci. Rep. 2020(10), 1\u20138 (2020).","journal-title":"Sci. Rep."},{"key":"16622_CR16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/rheumatology\/keaa686","volume":"60","author":"L Schittenhelm","year":"2021","unstructured":"Schittenhelm, L., Robertson, J., Pratt, A. G., Hilkens, C. M. & Morrison, V. L. Dendritic cell integrin expression patterns regulate inflammation in the rheumatoid arthritis joint. Rheumatology (Oxford) 60, 1533 (2021).","journal-title":"Rheumatology (Oxford)"},{"key":"16622_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1365-3083.1999.00602.x","volume":"50","author":"I Torsteinsd\u00f3ttir","year":"1999","unstructured":"Torsteinsd\u00f3ttir, I., Arvidson, N. G., H\u00e4llgren, N. G. & H\u00e5kansson, L. Enhanced expression of integrins and CD66b on peripheral blood neutrophils and eosinophils in patients with rheumatoid arthritis, and the effect of glucocorticoids. Scand. J. Immunol. 50, 433\u2013439 (1999).","journal-title":"Scand. J. Immunol."},{"key":"16622_CR18","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1186\/ar619","volume":"5","author":"A Maldonado","year":"2003","unstructured":"Maldonado, A. et al. Decreased effector memory CD45RA+ CD62L- CD8+ T cells and increased central memory CD45RA- CD62L+ CD8+ T cells in peripheral blood of rheumatoid arthritis patients. Arthritis Res. Ther. 5, R91 (2003).","journal-title":"Arthritis Res. Ther."},{"key":"16622_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1155\/2009\/510104","volume":"26","author":"RE Navarro-Hern\u00e1ndez","year":"2009","unstructured":"Navarro-Hern\u00e1ndez, R. E. et al. Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphisms. Dis. Markers 26, 119\u2013126 (2009).","journal-title":"Dis. Markers"},{"key":"16622_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/03009740701406460","volume":"36","author":"PA Klimiuk","year":"2007","unstructured":"Klimiuk, P. A., Fiedorczyk, M., Sierakowski, S. & Chwiecko, J. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. Scand. J. Rheumatol. 36, 345\u2013350 (2007).","journal-title":"Scand. J. Rheumatol."},{"key":"16622_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/03009740903079321","volume":"38","author":"PA Klimiuk","year":"2009","unstructured":"Klimiuk, P. A., Sierakowski, S., Domyslawska, I. & Chwiecko, J. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis. Scand. J. Rheumatol. 38, 439\u2013444 (2009).","journal-title":"Scand. J. Rheumatol."},{"key":"16622_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. 73, 492 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"16622_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.mayocp.2017.05.009","volume":"92","author":"CA Wijbrandts","year":"2017","unstructured":"Wijbrandts, C. A. & Tak, P. P. Prediction of response to targeted treatment in rheumatoid arthritis. Mayo Clin. Proc. 92, 1129\u20131143 (2017).","journal-title":"Mayo Clin. Proc."},{"key":"16622_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fimmu.2019.00203","volume":"10","author":"K Schinnerling","year":"2019","unstructured":"Schinnerling, K., Rosas, C., Soto, L., Thomas, R. & Aguill\u00f3n, J. C. Humanized mouse models of rheumatoid arthritis for studies on immunopathogenesis and preclinical testing of cell-based therapies. Front. Immunol. 10, 203 (2019).","journal-title":"Front. Immunol."},{"key":"16622_CR25","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1097\/MIB.0000000000000446","volume":"21","author":"I Koboziev","year":"2015","unstructured":"Koboziev, I. et al. Use of humanized mice to study the pathogenesis of autoimmune and inflammatory diseases. Inflamm. Bowel Dis. 21, 1652\u20131673 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"16622_CR26","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1101\/2021.02.19.431936","volume":"21","author":"M Rothbauer","year":"2021","unstructured":"Rothbauer, M. et al. Establishment of a human three-dimensional chip-based chondro-synovial co-culture joint model for reciprocal cross-talk studies in arthritis research. Lab Chip 21, 4128. https:\/\/doi.org\/10.1101\/2021.02.19.431936 (2021).","journal-title":"Lab Chip"},{"key":"16622_CR27","first-page":"1","volume":"21","author":"A Damerau","year":"2020","unstructured":"Damerau, A. & Gaber, T. Modeling rheumatoid arthritis in vitro: From experimental feasibility to physiological proximity. Int. J. Mol. Sci. 21, 1\u201325 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"16622_CR28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/cells10030596","volume":"10","author":"C Jorgensen","year":"2021","unstructured":"Jorgensen, C. & JSimon, M. In vitro human joint models combining advanced 3D Cell culture and cutting-edge 3D bioprinting technologies. Cells 10, 596 (2021).","journal-title":"Cells"},{"key":"16622_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bj.2020.06.010","volume":"44","author":"MI Edilova","year":"2021","unstructured":"Edilova, M. I., Akram, A. & Abdul-Sater, A. A. Innate immunity drives pathogenesis of rheumatoid arthritis. Biomed. J. 44, 172\u2013182 (2021).","journal-title":"Biomed. J."},{"issue":"9","key":"16622_CR30","first-page":"1","volume":"2019","author":"R Yamin","year":"2019","unstructured":"Yamin, R. et al. High percentages and activity of synovial fluid NK cells present in patients with advanced stage active rheumatoid arthritis. Sci. Rep. 2019(9), 1\u201312 (2019).","journal-title":"Sci. Rep."},{"key":"16622_CR31","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/art.39117","volume":"67","author":"J Talbot","year":"2015","unstructured":"Talbot, J. et al. CCR2 expression in neutrophils plays a critical role in their migration into the joints in rheumatoid arthritis. Arthritis Rheumatol. (Hoboken, NJ) 67, 1751\u20131759 (2015).","journal-title":"Arthritis Rheumatol. (Hoboken, NJ)"},{"key":"16622_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1756-185X.2009.01375.x","volume":"12","author":"P Vasanthi","year":"2009","unstructured":"Vasanthi, P., Nalini, G. & Rajasekhar, G. Status of oxidative stress in rheumatoid arthritis. Int. J. Rheum. Dis. 12, 29\u201333 (2009).","journal-title":"Int. J. Rheum. Dis."},{"key":"16622_CR33","first-page":"43","volume":"41","author":"S Adhya","year":"1998","unstructured":"Adhya, S. et al. Serology and immunoglobulin profile in rheumatoid arthritis. Indian J. Pathol. Microbiol. 41, 43\u201347 (1998).","journal-title":"Indian J. Pathol. Microbiol."},{"key":"16622_CR34","doi-asserted-by":"publisher","first-page":"e22560","DOI":"10.1371\/journal.pone.0022560","volume":"6","author":"S Yang","year":"2011","unstructured":"Yang, S., Liu, F., Wang, Q. J., Rosenberg, S. A. & Morgan, R. A. The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes. PLoS One 6, e22560 (2011).","journal-title":"PLoS One"},{"key":"16622_CR35","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","volume":"10","author":"A Ivetic","year":"2019","unstructured":"Ivetic, A., Hoskins Green, H. L. & Hart, S. J. L-selectin: A major regulator of leukocyte adhesion. Migr. Signal. Front. Immunol. 10, 1068 (2019).","journal-title":"Migr. Signal. Front. Immunol."},{"key":"16622_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fmed.2018.00052","volume":"0","author":"SQ Khan","year":"2018","unstructured":"Khan, S. Q., Khan, I. & Gupta, V. CD11b activity modulates pathogenesis of lupus nephritis. Front. Med. 0, 52 (2018).","journal-title":"Front. Med."},{"key":"16622_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejr.2014.12.002","volume":"37","author":"WA Hassan","year":"2015","unstructured":"Hassan, W. A., Baraka, E. A. & Fouad, N. A. Clinical significance of soluble programmed death-1(sPD-1) in rheumatoid arthritis patients: Relation to disease activity and functional status. Egypt. Rheumatol. 37, 165\u2013169 (2015).","journal-title":"Egypt. Rheumatol."},{"key":"16622_CR38","first-page":"3297","volume":"17","author":"Q Luo","year":"2018","unstructured":"Luo, Q. et al. Elevated expression of PD-1 on T cells correlates with disease activity in rheumatoid arthritis. Mol. Med. Rep. 17, 3297\u20133305 (2018).","journal-title":"Mol. Med. Rep."},{"key":"16622_CR39","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clim.2010.07.012","volume":"137","author":"Y Liu","year":"2010","unstructured":"Liu, Y. et al. Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin. Immunol. 137, 288\u2013295 (2010).","journal-title":"Clin. Immunol."},{"key":"16622_CR40","doi-asserted-by":"publisher","first-page":"8844","DOI":"10.4049\/jimmunol.177.12.8844","volume":"177","author":"B Wan","year":"2006","unstructured":"Wan, B. et al. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J. Immunol. 177, 8844\u20138850 (2006).","journal-title":"J. Immunol."},{"key":"16622_CR41","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1073\/pnas.0806855105","volume":"105","author":"F Flores-Borja","year":"2008","unstructured":"Flores-Borja, F., Jury, E. C., Mauri, C. & Ehrenstein, M. R. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 105, 19396\u201319401 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"16622_CR42","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/rheumatology\/keg323","volume":"42","author":"AH Gerards","year":"2003","unstructured":"Gerards, A. H., de Lathouder, S., de Groot, E. R., Dijkmans, B. A. C. & Aarden, L. A. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. Rheumatology 42, 1189\u20131196 (2003).","journal-title":"Rheumatology"},{"key":"16622_CR43","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1186\/ar4615","volume":"16","author":"C Zamora-Atenza","year":"2014","unstructured":"Zamora-Atenza, C. et al. Adalimumab regulates intracellular TNF\u03b1 production in patients with rheumatoid arthritis. Arthritis Res. Ther. 16, R153 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"16622_CR44","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/rheumatology\/keg171","volume":"42","author":"AJ Schuerwegh","year":"2003","unstructured":"Schuerwegh, A. J., Van Offel, J. F., Stevens, W. J., Bridts, C. H. & De Clerck, L. S. Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients. Rheumatology (Oxford). 42, 541\u2013548 (2003).","journal-title":"Rheumatology (Oxford)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16622-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16622-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16622-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:12:36Z","timestamp":1669349556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16622-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16622"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16622-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,16]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.C.G. and J.M.B. are current employees of Beckman Coulter Life Sciences. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12166"}}